Company’s 36-month beta value is -1.59.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for AZTR is 17.09M, and currently, short sellers hold a 3.84% ratio of that floaft. The average trading volume of AZTR on July 10, 2025 was 2.89M shares.
AZTR) stock’s latest price update
Azitra Inc (AMEX: AZTR)’s stock price has soared by 9.91% in relation to previous closing price of $0.23. Nevertheless, the company has seen a loss of -5.07% in its stock price over the last five trading days. prnewswire.com reported 2025-06-17 that Drug candidate ATR12-351 has been generally safe and well-tolerated with occasional, transient, mild to moderate symptoms at application site Trial is 50% enrolled; six patients have received ATR12-351, a live precision dermatology therapeutic candidate Azitra presenting at the 2025 BIO International Convention BRANFORD, Conn., June 17, 2025 /PRNewswire/ — Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced encouraging safety data from the initial clinical trial of its live biotherapeutic candidate, ATR12-351, targeting Netherton syndrome.
AZTR’s Market Performance
Azitra Inc (AZTR) has experienced a -5.07% fall in stock performance for the past week, with a -8.07% drop in the past month, and a -10.38% drop in the past quarter. The volatility ratio for the week is 7.83%, and the volatility levels for the past 30 days are at 9.14% for AZTR. The simple moving average for the past 20 days is -2.48% for AZTR’s stock, with a -32.94% simple moving average for the past 200 days.
AZTR Trading at -8.69% from the 50-Day Moving Average
After a stumble in the market that brought AZTR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -97.89% of loss for the given period.
Stock Fundamentals for AZTR
Current profitability levels for the company are sitting at:
- -1877.66 for the present operating margin
- 1.02 for the gross margin
The net margin for Azitra Inc stands at -409.92. The total capital return value is set at -3.04. Equity return is now at value -208.50, with -152.02 for asset returns.
Based on Azitra Inc (AZTR), the company’s capital structure generated 0.1 points at debt to capital in total, while cash flow to debt ratio is standing at -6.5. The debt to equity ratio resting at 0.11. The interest coverage ratio of the stock is 10986.82.
Currently, EBITDA for the company is -10.99 billion with net debt to EBITDA at 0.19. When we switch over and look at the enterprise to sales, we see a ratio of -363.82. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.02.
Conclusion
In a nutshell, Azitra Inc (AZTR) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
